| Bioactivity | Broxaldine (Brobenzoxaldine) is an antiprotozoal agent. Broxaldine inhibits Clostridium difficile with a MIC value of 4 µM, and has antifungal effects[1][2]. | ||||||||||||
| Invitro | Broxaldine (Brobenzoxaldine) is an antiprotozoal drug. | ||||||||||||
| Name | Broxaldine | ||||||||||||
| CAS | 3684-46-6 | ||||||||||||
| Formula | C17H11Br2NO2 | ||||||||||||
| Molar Mass | 421.08 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hazra SK, et al. Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy. Lepr India. 1979 Oct;51(4):505-10. [2]. AbdelKhalek A, et al. Screening for potent and selective anticlostridial leads among FDA-approved drugs. J Antibiot (Tokyo). 2020 Mar 4. |
Broxaldine
CAS: 3684-46-6 F: C17H11Br2NO2 W: 421.08
Broxaldine (Brobenzoxaldine) is an antiprotozoal agent. Broxaldine inhibits Clostridium difficile with a MIC value of 4
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.